Sedana Medical AB (SEDANA) - Total Assets
Based on the latest financial reports, Sedana Medical AB (SEDANA) holds total assets worth Skr954.46 Million SEK (≈ $102.72 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See SEDANA total equity for net asset value and shareholders' equity analysis.
Sedana Medical AB - Total Assets Trend (2015–2025)
This chart illustrates how Sedana Medical AB's total assets have evolved over time, based on quarterly financial data.
Sedana Medical AB - Asset Composition Analysis
Current Asset Composition (December 2025)
Sedana Medical AB's total assets of Skr954.46 Million consist of 18.2% current assets and 81.8% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 9.5% |
| Accounts Receivable | Skr40.89 Million | 4.3% |
| Inventory | Skr37.87 Million | 4.0% |
| Property, Plant & Equipment | Skr0.00 | 0.0% |
| Intangible Assets | Skr744.93 Million | 78.1% |
| Goodwill | Skr25.28 Million | 2.7% |
Asset Composition Trend (2015–2025)
This chart illustrates how Sedana Medical AB's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market value of Sedana Medical AB.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Sedana Medical AB's current assets represent 18.2% of total assets in 2025, a decrease from 89.2% in 2015.
- Cash Position: Cash and equivalents constituted 9.5% of total assets in 2025, down from 25.6% in 2015.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 80.0% of total assets, an increase from 6.0% in 2015.
- Asset Diversification: The largest asset category is intangible assets at 78.1% of total assets.
Sedana Medical AB Competitors by Total Assets
Key competitors of Sedana Medical AB based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
INKON Life Technology Co Ltd
SHE:300143
|
China | CN¥4.15 Billion |
|
CareRay Digital Medical Technology Co Ltd
SHG:688607
|
China | CN¥988.48 Million |
|
Senseonics Holdings, Inc. Common Stock
NYSE MKT:SENS
|
USA | $139.92 Million |
|
Universus Photo Imagings Limited
NSE:UNIVPHOTO
|
India | Rs8.57 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
|
Aligned Genetics Inc
KQ:238120
|
Korea | ₩45.11 Billion |
|
Heramed Ltd
AU:HMD
|
Australia | AU$1.04 Million |
|
Acarix A/S
ST:ACARIX
|
Sweden | Skr48.33 Million |
Sedana Medical AB - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.40 | 5.39 | 9.83 |
| Quick Ratio | 2.66 | 4.50 | 9.52 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Skr122.72 Million | Skr226.55 Million | Skr344.02 Million |
Sedana Medical AB - Advanced Valuation Insights
This section examines the relationship between Sedana Medical AB's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.08 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -6.4% |
| Total Assets | Skr954.46 Million |
| Market Capitalization | $110.32 Million USD |
Valuation Analysis
Below Book Valuation: The market values Sedana Medical AB's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Sedana Medical AB's assets decreased by 6.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Sedana Medical AB (2015–2025)
The table below shows the annual total assets of Sedana Medical AB from 2015 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Skr954.46 Million ≈ $102.72 Million |
-6.37% |
| 2024-12-31 | Skr1.02 Billion ≈ $109.70 Million |
+0.53% |
| 2023-12-31 | Skr1.01 Billion ≈ $109.13 Million |
-6.24% |
| 2022-12-31 | Skr1.08 Billion ≈ $116.40 Million |
-7.36% |
| 2021-12-31 | Skr1.17 Billion ≈ $125.65 Million |
+94.57% |
| 2020-12-31 | Skr600.10 Million ≈ $64.58 Million |
+1.15% |
| 2019-12-31 | Skr593.25 Million ≈ $63.84 Million |
+156.21% |
| 2018-12-31 | Skr231.55 Million ≈ $24.92 Million |
+76.25% |
| 2017-12-31 | Skr131.38 Million ≈ $14.14 Million |
+473.62% |
| 2016-12-31 | Skr22.90 Million ≈ $2.46 Million |
+84.69% |
| 2015-12-31 | Skr12.40 Million ≈ $1.33 Million |
-- |
About Sedana Medical AB
Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; S… Read more